Hall Patricia, Minnich Sara, Teigen Claire, Raymond Kimiyo
Department of Human Genetics, Emory University, Atlanta, Georgia.
Curr Protoc Hum Genet. 2014 Oct 1;83:17.16.1-8. doi: 10.1002/0471142905.hg1716s83.
The GM2 gangliosidoses are a group of autosomal recessive lysosomal storage disorders caused by defective β-hexosaminidase. There are three clinical conditions in this group: Tay-Sachs disease (TSD), Sandhoff disease (SD), and hexosaminidase activator deficiency. The three conditions are clinically indistinguishable. TSD and SD have been identified with infantile, juvenile, and adult onset forms. The activator deficiency is only known to present with infantile onset. Diagnosis of TSD and SD is based on decreased hexosaminidase activity and a change in the percentage of activity between isoforms. There are no biochemical tests currently available for activator deficiency. This unit provides a detailed procedure for identifying TSD and SD in affected individuals and carriers from leukocyte samples, the most robust sample type available.
GM2神经节苷脂沉积症是一组由β-己糖胺酶缺陷引起的常染色体隐性溶酶体贮积病。该组有三种临床病症:泰-萨克斯病(TSD)、桑德霍夫病(SD)和己糖胺酶激活剂缺乏症。这三种病症在临床上无法区分。TSD和SD已被确定有婴儿型、青少年型和成人型。激活剂缺乏症仅已知表现为婴儿型发病。TSD和SD的诊断基于己糖胺酶活性降低以及同工型之间活性百分比的变化。目前尚无针对激活剂缺乏症的生化检测方法。本单元提供了一种详细程序,用于从白细胞样本(现有最可靠的样本类型)中识别受影响个体和携带者中的TSD和SD。